IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 61 filers reported holding IBERE PHARMACEUTICALS in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,944,000 | – | 400,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hartree Partners, LP | 1,285,000 | $12,914,250,000 | 3.01% |
Wealthspring Capital LLC | 277,192 | $2,786,000 | 0.70% |
BASSO CAPITAL MANAGEMENT, L.P. | 135,404 | $1,361,000 | 0.17% |
Omni Partners US LLC | 364,371 | $3,662,000 | 0.16% |
Sage Mountain Advisors LLC | 93,470 | $939,000 | 0.16% |
Castle Creek Arbitrage, LLC | 253,446 | $2,540,000 | 0.14% |
Shaolin Capital Management LLC | 396,200 | $3,982,000 | 0.12% |
Context Capital Management, LLC | 115,053 | $1,156,000 | 0.11% |
PERISCOPE CAPITAL INC. | 250,000 | $2,512,000 | 0.08% |
Magnetar Financial LLC | 803,400 | $8,074,000 | 0.08% |